The factors influencing the growth of the market are the rising demand for supplements in the health & wellness industry, the growing prominence of sports nutrition, the trend of active living, the increasing demand for nutraceutical products, etc.
New York, Jan. 19, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “GLOBAL DIETARY SUPPLEMENTS MARKET FORECAST 2019-2028” – https://www.reportlinker.com/p06007671/?utm_source=GNW
MARKET INSIGHTS
Dietary supplements are products rich in minerals, vitamins, enzymes, herbs, amino acids, etc.Their primary aim is to meet the nutritional needs so as to prevent diseases.
Active living is a growing trend across the globe.An unhealthy diet is one of the several reasons for the increased risk of cancer, obesity, diabetes, and cardiovascular diseases.
There is an increasing awareness regarding dietary and nutrient supplements, along with an increasing preference for healthy & active living. Countries like the UK, France, Italy, etc., witness increased demands for food supplements. This is because there is an increasing focus on preventing illness or disease over the absence of disease. Also, the rising popularity of organic & herbal products is contributing to market growth. However, regulatory concerns, easy availability of counterfeit products, and growing demand for functional foods, are hindering the market growth.
REGIONAL INSIGHTS
The global dietary supplements market’s geographical growth analysis includes the assessment of North America, Europe, Asia Pacific, and rest of world.The Asia Pacific region is set to harbor the largest market share in the global market by 2028.
The ample availability of raw materials, along with the rising geriatric population, benefits the growth of the region.
COMPETITIVE INSIGHTS
The market is highly competitive, with a large number of manufacturers.Companies are projected to increase expenditure for establishing strategic partnerships with retail chain companies.
Some of the eminent companies in the market are Bayer AG, Abbott Laboratories, GlaxoSmithKline Plc, Herbalife Ltd, Glanbia Plc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Companies mentioned
1. ABBOTT LABORATORIES
2. BAYER AG
3. GLANBIA PLC
4. GLAXOSMITHKLINE PLC
5. HERBALIFE LTD
6. MERCK KGAA
7. OTSUKA HOLDINGS CO LTD
8. PFIZER
9. RECKITT BENCKISER GROUP PLC
10. SANOFI SA
11. SUNTORY HOLDINGS LTD
12. NATURE’S BOUNTY
13. AMWAY CORPORATION
14. GNC HOLDINGS
15. BLACKMORES LTD
Read the full report: https://www.reportlinker.com/p06007671/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
NEW YORK, July 4, 2024 /PRNewswire/ -- The global breast tissue expander market size is estimated to…
CHICAGO, July 4, 2024 /PRNewswire/ -- The global microscopy market is poised for significant growth, expected…
Toronto, Ontario--(Newsfile Corp. - July 4, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE)…
MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) -- Global biotechnology leader CSL Behring (ASX: CSL)…
SKYSCRAPER-06 evaluating tiragolumab plus Tecentriq and chemotherapy did not meet the primary endpoints of progression-free…
ICPO Center NuMeRI ICPO Foundation signed the contract with Nuclear Medicine Research Infrastructure (NuMeRI) to…